Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 5
2021 6
2022 1
2023 6
2024 4
2025 6
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Hot topics in hepatocellular carcinoma.
Ielasi L, Goio E, Tovoli F. Ielasi L, et al. Transl Cancer Res. 2019 Apr;8(Suppl 3):S216-S218. doi: 10.21037/tcr.2018.08.01. Transl Cancer Res. 2019. PMID: 35117101 Free PMC article. No abstract available.
Donafenib in hepatocellular carcinoma.
Chen R, Ielasi L, di Carlo A, Tovoli F. Chen R, et al. Among authors: ielasi l. Drugs Today (Barc). 2023 Feb;59(2):83-90. doi: 10.1358/dot.2023.59.2.3507751. Drugs Today (Barc). 2023. PMID: 36811408 Review.
Treatment of Combined Hepatocellular and Cholangiocarcinoma.
Leoni S, Sansone V, Lorenzo S, Ielasi L, Tovoli F, Renzulli M, Golfieri R, Spinelli D, Piscaglia F. Leoni S, et al. Among authors: ielasi l. Cancers (Basel). 2020 Mar 26;12(4):794. doi: 10.3390/cancers12040794. Cancers (Basel). 2020. PMID: 32224916 Free PMC article. Review.
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab.
Stefanini B, Piscaglia F, Marra F, Iavarone M, Vivaldi C, Cabibbo G, Palloni A, Pressiani T, Dalbeni A, Stefanini B, Stella L, Federico P, Svegliati-Baroni G, Lonardi S, Soldà C, Ielasi L, De Lorenzo S, Garajova I, Campani C, Bruccoleri M, Masi G, Celsa C, Brandi G, Auriemma A, Daniele B, Ponziani FR, Lani L, Chen R, Boe M, Granito A, Rimassa L, Tovoli F; ARTE study group. Stefanini B, et al. Among authors: ielasi l. Liver Cancer. 2025 May 26;15(1):10-23. doi: 10.1159/000545494. eCollection 2026 Feb. Liver Cancer. 2025. PMID: 40567390 Free PMC article.
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison.
Giuliante F, Famularo S, Grasselli S, Sangiovanni A, Vitale A, Cabibbo G, Lauterio A, Cipriani F, Saccomandi A, Arru M, Pinto E, Brunetto MR, Franzè MS, Graziosi C, Campani C, Marra F, Di Marco M, Marseglia M, Santi V, Capasso M, Masotto A, Fontana A, Iaria M, Rocco A, Serenari M, Mega A, Gasbarrini A, Plaz Torres MC, Garancini M, Conci S, Dajti E, Perri P, Sacco R, Giglio M, Ferari C, De Angelis M, Troci A, Magalotti D, Nicolini D, Zimmitti G, Germani P, Schiadà L, Conticchio M, Zanello M, Romano M, Milana F, Lai Q, Patauner S, Frena A, Rossi M, Torzilli G, Zanus G, Jovine E, Memeo R, Svegliati-Baroni G, Tarchi P, Hilal MA, Vivarelli M, Crespi M, Boccia L, Griseri G, Troisi RI, Grazi GL, Azzaroli F, Ruzzenente A, Romano F, Giannini EG, Cescon M, Nardone G, Valle RD, Ferrero A, Morisco F, Piscaglia F, Ghittoni G, Saitta C, Pelizzaro F, Vidili G, Foschi FG, Aldrighetti L, De Carlis L, Cillo U, Biasini E, Bernasconi D, Ardito F, Trevisani F; HE.RC.O.LE.S. and the ITA.LI.CA. groups. Giuliante F, et al. JHEP Rep. 2025 Apr 25;7(8):101420. doi: 10.1016/j.jhepr.2025.101420. eCollection 2025 Aug. JHEP Rep. 2025. PMID: 40689143 Free PMC article.
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
Pasta A, Pieri G, Plaz Torres MC, Missale G, Foschi FG, Piscaglia F, Boninsegna S, Mega A, Cazzagon N, Pelizzaro F, Viganò M, Trevisani F, Bucci L, Azzaroli F, Brunetto MR, Campani C, Celsa C, Ghittoni G, Magalotti D, Martini A, Morisco F, Nardone G, Ponziani FR, Sacco R, Sacerdoti D, Saitta C, Sangiovanni A, Lani L, Svegliati-Baroni G, Vidili G, Vitale A, Giannini EG; Italian Liver Cancer (ITA.LI.CA) Group. Pasta A, et al. Dig Dis Sci. 2025 Aug;70(8):2865-2872. doi: 10.1007/s10620-025-09064-1. Epub 2025 May 3. Dig Dis Sci. 2025. PMID: 40317369 Free PMC article.
Outcome of hepatic resection for HCC in ideal and non-ideal candidates.
Lani L, Bucci L, Santi V, Stefanini B, Stefanini B, Sangiovanni A, Grasselli S, Ghittoni G, Saitta C, Morisco F, Cabibbo G, Marra F, Vidili G, Brunetto MR, Foschi FG, Di Marco M, Svegliati-Baroni G, Pelizzaro F, Azzaroli F, Ponziani FR, Martini A, Sacerdoti D, Mega A, Boninsegna S, Giannini EG, Magalotti D, Sacco R, Nardone G, Caraceni P, Vitale A, Trevisani F; and the Italian Liver Cancer group. Lani L, et al. Hepatol Commun. 2025 Jul 29;9(8):e0772. doi: 10.1097/HC9.0000000000000772. eCollection 2025 Aug 1. Hepatol Commun. 2025. PMID: 40719550 Free PMC article.
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study.
Giannini EG, Pasta A, Bucci L, Plaz Torres MC, Pieri G, Celsa C, Sangiovanni A, Piscaglia F, Campani C, Missale G, Vidili G, Ghittoni G, Pelizzaro F, Foschi FG, Morisco F, Santi V, Svegliati-Baroni G, Azzaroli F, Saitta C, Brunetto MR, Sacco R, Ponziani FR, Boninsegna S, Nardone G, Martini A, Mega A, Sacerdoti D, Magalotti D, Vitale A, Trevisani F; Italian Liver Cancer (ITA.LI.CA) Group. Giannini EG, et al. Dig Liver Dis. 2025 Aug;57(8):1673-1682. doi: 10.1016/j.dld.2025.05.032. Epub 2025 Jun 26. Dig Liver Dis. 2025. PMID: 40579332 Free article.
TKIs in combination with immunotherapy for hepatocellular carcinoma.
Stefanini B, Ielasi L, Chen R, Abbati C, Tonnini M, Tovoli F, Granito A. Stefanini B, et al. Among authors: ielasi l. Expert Rev Anticancer Ther. 2023 Mar;23(3):279-291. doi: 10.1080/14737140.2023.2181162. Epub 2023 Feb 26. Expert Rev Anticancer Ther. 2023. PMID: 36794716 Review.
Experience with regorafenib in the treatment of hepatocellular carcinoma.
Granito A, Forgione A, Marinelli S, Renzulli M, Ielasi L, Sansone V, Benevento F, Piscaglia F, Tovoli F. Granito A, et al. Among authors: ielasi l. Ther Adv Gastroenterol. 2021 May 28;14:17562848211016959. doi: 10.1177/17562848211016959. eCollection 2021. Ther Adv Gastroenterol. 2021. PMID: 34104211 Free PMC article. Review.
31 results